Recurrent vulvovaginal candidiasis
BACKGROUND: Recurrent vulvovaginal candidiasis affects up to 5% of premenopausal women. It is often associated with significant morbidity and may be difficult to manage. OBJECTIVE: This article discusses the pathogenesis investigations and management of recurrent vulvovaginal candidiasis. DISCUSSION...
Gespeichert in:
| Veröffentlicht in: | Australian family physician 2005-03, Vol.34 (3), p.147-150 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 150 |
|---|---|
| container_issue | 3 |
| container_start_page | 147 |
| container_title | Australian family physician |
| container_volume | 34 |
| creator | Sheary, Belinda Dayan, Linda |
| description | BACKGROUND: Recurrent vulvovaginal candidiasis affects up to 5% of premenopausal women. It is often associated with significant morbidity and may be difficult to manage. OBJECTIVE: This article discusses the pathogenesis investigations and management of recurrent vulvovaginal candidiasis. DISCUSSION: Recurrent vulvovaginal candidiasis may be misdiagnosed as presenting signs and symptoms are not specific. Examination and microbial testing are required to confirm the diagnosis. Some women appear to have an abnormal host response to the presence of candida species in the vagina, making them susceptible to recurrent episodes of symptomatic infection. Women with recurrent vulvovaginal candidiasis generally respond to a course of suppressive treatment, but many relapse after ceasing therapy. (author abstract) |
| doi_str_mv | 10.2267/0300-8495.34.3.1738 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67565774</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><informt_id>10.3316/informit.369610285681810</informt_id><sourcerecordid>67565774</sourcerecordid><originalsourceid>FETCH-LOGICAL-p232t-3052bc24515b48c1c496311f90e5a5b3cf5841aaa46503a2eed20b7fb9dbd5e03</originalsourceid><addsrcrecordid>eNpdz11LwzAUBuBcKG5Of4EgYxfetSY5-WgvZfgFA0EUvAtJms6MtplJO_DfW9xU8OrAeR9ezkHoguCcUiGvMWCcFazkObAcciKhOELT3-0Enaa0wZgykHCCJoTLshQCpmjx7OwQo-v6-W5odmGn177TzdzqrvKV18mnM3Rc6ya588Ocode725flQ7Z6un9c3qyyLQXaZ4A5NZYyTrhhhSWWlQIIqUvsuOYGbM0LRrTWTHAMmjpXUWxkbcrKVNxhmKGrfe82ho_BpV61PlnXNLpzYUhKSC64lGyEi39wE4Y4Xp0UJYKWgopiRJcHNJjWVWobfavjp_p5fQRvexBb3ysbmsbZ3ocubXSfVHI62nfluzp85yGuVRW80iYpghUAEX8hiFIQTAsuClIQDF8Ka3c2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216296268</pqid></control><display><type>article</type><title>Recurrent vulvovaginal candidiasis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Sheary, Belinda ; Dayan, Linda</creator><creatorcontrib>Sheary, Belinda ; Dayan, Linda</creatorcontrib><description>BACKGROUND: Recurrent vulvovaginal candidiasis affects up to 5% of premenopausal women. It is often associated with significant morbidity and may be difficult to manage. OBJECTIVE: This article discusses the pathogenesis investigations and management of recurrent vulvovaginal candidiasis. DISCUSSION: Recurrent vulvovaginal candidiasis may be misdiagnosed as presenting signs and symptoms are not specific. Examination and microbial testing are required to confirm the diagnosis. Some women appear to have an abnormal host response to the presence of candida species in the vagina, making them susceptible to recurrent episodes of symptomatic infection. Women with recurrent vulvovaginal candidiasis generally respond to a course of suppressive treatment, but many relapse after ceasing therapy. (author abstract)</description><identifier>ISSN: 0300-8495</identifier><identifier>ISSN: 2208-7958</identifier><identifier>DOI: 10.2267/0300-8495.34.3.1738</identifier><identifier>PMID: 15799663</identifier><language>eng</language><publisher>Australia: Copyright Agency Limited (Distributor)</publisher><subject>Antifungal Agents - therapeutic use ; Candidiasis, Vulvovaginal ; Candidiasis, Vulvovaginal - diagnosis ; Candidiasis, Vulvovaginal - physiopathology ; Candidiasis, Vulvovaginal - therapy ; Drug Resistance, Fungal ; Family medicine ; Family Practice - methods ; Female ; Humans ; Medical technology ; Practice Guidelines as Topic ; Recurrence ; Treatment</subject><ispartof>Australian family physician, 2005-03, Vol.34 (3), p.147-150</ispartof><rights>Copyright Copyright Agency Limited (Distributor) Mar 2005</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15799663$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sheary, Belinda</creatorcontrib><creatorcontrib>Dayan, Linda</creatorcontrib><title>Recurrent vulvovaginal candidiasis</title><title>Australian family physician</title><addtitle>Aust Fam Physician</addtitle><description>BACKGROUND: Recurrent vulvovaginal candidiasis affects up to 5% of premenopausal women. It is often associated with significant morbidity and may be difficult to manage. OBJECTIVE: This article discusses the pathogenesis investigations and management of recurrent vulvovaginal candidiasis. DISCUSSION: Recurrent vulvovaginal candidiasis may be misdiagnosed as presenting signs and symptoms are not specific. Examination and microbial testing are required to confirm the diagnosis. Some women appear to have an abnormal host response to the presence of candida species in the vagina, making them susceptible to recurrent episodes of symptomatic infection. Women with recurrent vulvovaginal candidiasis generally respond to a course of suppressive treatment, but many relapse after ceasing therapy. (author abstract)</description><subject>Antifungal Agents - therapeutic use</subject><subject>Candidiasis, Vulvovaginal</subject><subject>Candidiasis, Vulvovaginal - diagnosis</subject><subject>Candidiasis, Vulvovaginal - physiopathology</subject><subject>Candidiasis, Vulvovaginal - therapy</subject><subject>Drug Resistance, Fungal</subject><subject>Family medicine</subject><subject>Family Practice - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Medical technology</subject><subject>Practice Guidelines as Topic</subject><subject>Recurrence</subject><subject>Treatment</subject><issn>0300-8495</issn><issn>2208-7958</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdz11LwzAUBuBcKG5Of4EgYxfetSY5-WgvZfgFA0EUvAtJms6MtplJO_DfW9xU8OrAeR9ezkHoguCcUiGvMWCcFazkObAcciKhOELT3-0Enaa0wZgykHCCJoTLshQCpmjx7OwQo-v6-W5odmGn177TzdzqrvKV18mnM3Rc6ya588Ocode725flQ7Z6un9c3qyyLQXaZ4A5NZYyTrhhhSWWlQIIqUvsuOYGbM0LRrTWTHAMmjpXUWxkbcrKVNxhmKGrfe82ho_BpV61PlnXNLpzYUhKSC64lGyEi39wE4Y4Xp0UJYKWgopiRJcHNJjWVWobfavjp_p5fQRvexBb3ysbmsbZ3ocubXSfVHI62nfluzp85yGuVRW80iYpghUAEX8hiFIQTAsuClIQDF8Ka3c2</recordid><startdate>20050301</startdate><enddate>20050301</enddate><creator>Sheary, Belinda</creator><creator>Dayan, Linda</creator><general>Copyright Agency Limited (Distributor)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AYAGU</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20050301</creationdate><title>Recurrent vulvovaginal candidiasis</title><author>Sheary, Belinda ; Dayan, Linda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p232t-3052bc24515b48c1c496311f90e5a5b3cf5841aaa46503a2eed20b7fb9dbd5e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Antifungal Agents - therapeutic use</topic><topic>Candidiasis, Vulvovaginal</topic><topic>Candidiasis, Vulvovaginal - diagnosis</topic><topic>Candidiasis, Vulvovaginal - physiopathology</topic><topic>Candidiasis, Vulvovaginal - therapy</topic><topic>Drug Resistance, Fungal</topic><topic>Family medicine</topic><topic>Family Practice - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Medical technology</topic><topic>Practice Guidelines as Topic</topic><topic>Recurrence</topic><topic>Treatment</topic><toplevel>online_resources</toplevel><creatorcontrib>Sheary, Belinda</creatorcontrib><creatorcontrib>Dayan, Linda</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>Australia & New Zealand Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Australian family physician</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sheary, Belinda</au><au>Dayan, Linda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recurrent vulvovaginal candidiasis</atitle><jtitle>Australian family physician</jtitle><addtitle>Aust Fam Physician</addtitle><date>2005-03-01</date><risdate>2005</risdate><volume>34</volume><issue>3</issue><spage>147</spage><epage>150</epage><pages>147-150</pages><issn>0300-8495</issn><issn>2208-7958</issn><abstract>BACKGROUND: Recurrent vulvovaginal candidiasis affects up to 5% of premenopausal women. It is often associated with significant morbidity and may be difficult to manage. OBJECTIVE: This article discusses the pathogenesis investigations and management of recurrent vulvovaginal candidiasis. DISCUSSION: Recurrent vulvovaginal candidiasis may be misdiagnosed as presenting signs and symptoms are not specific. Examination and microbial testing are required to confirm the diagnosis. Some women appear to have an abnormal host response to the presence of candida species in the vagina, making them susceptible to recurrent episodes of symptomatic infection. Women with recurrent vulvovaginal candidiasis generally respond to a course of suppressive treatment, but many relapse after ceasing therapy. (author abstract)</abstract><cop>Australia</cop><pub>Copyright Agency Limited (Distributor)</pub><pmid>15799663</pmid><doi>10.2267/0300-8495.34.3.1738</doi><tpages>147-50</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0300-8495 |
| ispartof | Australian family physician, 2005-03, Vol.34 (3), p.147-150 |
| issn | 0300-8495 2208-7958 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67565774 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Antifungal Agents - therapeutic use Candidiasis, Vulvovaginal Candidiasis, Vulvovaginal - diagnosis Candidiasis, Vulvovaginal - physiopathology Candidiasis, Vulvovaginal - therapy Drug Resistance, Fungal Family medicine Family Practice - methods Female Humans Medical technology Practice Guidelines as Topic Recurrence Treatment |
| title | Recurrent vulvovaginal candidiasis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T14%3A49%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recurrent%20vulvovaginal%20candidiasis&rft.jtitle=Australian%20family%20physician&rft.au=Sheary,%20Belinda&rft.date=2005-03-01&rft.volume=34&rft.issue=3&rft.spage=147&rft.epage=150&rft.pages=147-150&rft.issn=0300-8495&rft_id=info:doi/10.2267/0300-8495.34.3.1738&rft_dat=%3Cproquest_pubme%3E67565774%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216296268&rft_id=info:pmid/15799663&rft_informt_id=10.3316/informit.369610285681810&rfr_iscdi=true |